GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (FRA:WF6) » Definitions » Long-Term Debt

MindBio Therapeutics (FRA:WF6) Long-Term Debt : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Long-Term Debt?

MindBio Therapeutics's Long-Term Debt for the quarter that ended in Dec. 2024 was €0.00 Mil.

MindBio Therapeutics's annual Long-Term Debt declined from Jun. 2022 (€2.99 Mil) to Jun. 2023 (€1.75 Mil) and declined from Jun. 2023 (€1.75 Mil) to Jun. 2024 (€0.00 Mil).


MindBio Therapeutics Long-Term Debt Historical Data

The historical data trend for MindBio Therapeutics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Long-Term Debt Chart

MindBio Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Long-Term Debt
- 2.99 1.75 -

MindBio Therapeutics Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.42 2.41 - - -

MindBio Therapeutics  (FRA:WF6) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


MindBio Therapeutics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


MindBio Therapeutics Business Description

Traded in Other Exchanges
Address
91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000
MindBio Therapeutics Corp is engaged in the research, development, and testing of psychedelic substances as a potential treatment for the management of a broad range of mental health conditions. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough micro dosing studies. Geographically, the company's activities take place in Australia.

MindBio Therapeutics Headlines

No Headlines